Neuroprotective effects of bioavailable polyphenol-derived metabolites against oxidative stress-induced cytotoxicity in human neuroblastoma SH-SY5Y cells

Journal of Agricultural and Food Chemistry

Volumn 65, Issue 4, 2017, Pages 752-758

  González Sarrías, Antonio ^a   Núñez Sánchez, María Ángeles ^a   Tomás Barberán, Francisco A ^a   Espín, Juan Carlos ^a  

^a RESEARCH GROUP ON QUALITY   (Spain)

Author keywords

Ellagic acid; Gallic acid; Neuroprotective effects; Phenolic acids; Polyphenol; Urolithins

Indexed keywords

BIOMOLECULES; CELL DEATH; ELLAGIC ACID; METABOLITES; OXIDATIVE STRESS; REDOX REACTIONS;

GALLIC ACIDS; NEUROPROTECTIVE EFFECTS; PHENOLIC ACIDS; POLYPHENOLS; UROLITHINS;

NEURODEGENERATIVE DISEASES;

CASPASE 3; NEUROPROTECTIVE AGENT; POLYPHENOL;

APOPTOSIS; CHEMICAL STRUCTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; HUMAN; METABOLISM; NERVE CELL; OXIDATIVE STRESS; TUMOR CELL LINE;

APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; HUMANS; MOLECULAR STRUCTURE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; POLYPHENOLS;

EID: 85011278984     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.6b04538     Document Type: Article

References (48)

1. Tabner, B. J.; El-Agnaf, O. M.; Turnbull, S.; German, M. J.; Paleologou, K. E.; Hayashi, Y.; Cooper, L. J.; Fullwood, N. J.; Allsop, D. Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in Alzheimer disease and familial British dementia. J. Biol. Chem. 2005, 280, 35789-35792.
2. Uttara, B.; Singh, A. V.; Zamboni, P.; Mahajan, R. T. Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Curr. Neuropharmacol. 2009, 7, 65-74.
3. Rosini, M.; Simoni, E.; Milelli, A.; Minarini, A.; Melchiorre, C. Oxidative stress in Alzheimer's disease: are we connecting the dots? J. Med. Chem. 2014, 57, 2821-2831.
4. Dai, Q.; Borenstein, A. R.; Wu, Y.; Jackson, J. C.; Larson, E. B. Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am. J. Med. 2006, 119, 751-759.
5. Letenneur, L.; Proust-Lima, C.; Le Gouge, A.; Dartigues, J. F.; Barberger-Gateau, P. Flavonoid intake and cognitive decline over a 10-year period. Am. J. Epidemiol. 2007, 165, 1364-1371.
6. Singh, M.; Arseneault, M.; Sanderson, T.; Murthy, V.; Ramassamy, C. Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 2008, 56, 4855-4873.
7. Panickar, K. S.; Jang, S. Dietary and plant polyphenols exert neuroprotective effects and improve cognitive function in cerebral ischemia. Recent Pat. Food, Nutr. Agric. 2013, 5, 128-143.
8. Ahmed, A. H.; Subaiea, G. M.; Eid, A.; Li, L.; Seeram, N. P.; Zawia, N. H. Pomegranate extract modulates processing of amyloid-β precursor protein in an aged Alzheimer's disease animal model. Curr. Alzheimer Res. 2014, 11, 834-843.
9. Hartman, R. E.; Shah, A.; Fagan, A. M.; Schwetye, K. E.; Parsadanian, M.; Schulman, R. N.; Finn, M. B.; Holtzman, D. M. Pomegranate juice decreases amyloid load and improves behavior in a mouse model of Alzheimer's disease. Neurobiol. Dis. 2006, 24, 506-515.
10. Rojanathammanee, L.; Puig, K. L.; Combs, C. K. Pomegranate polyphenols and extract inhibit nuclear factor of activated T-cell activity and microglial activation in vitro and in a transgenic mouse model of Alzheimer disease. J. Nutr. 2013, 143, 597-605.
11. Singh, N.; Agrawal, M.; Dore, S. Neuroprotective properties and mechanisms of resveratrol in in vitro and in vivo experimental cerebral stroke models. ACS Chem. Neurosci. 2013, 4, 1151-1162.
12. Selma, M. V.; Espín, J. C.; Tomas-Barberan, F. A. Interaction between phenolics and gut microbiota: role in human health. J. Agric. Food Chem. 2009, 57, 6485-6501.
13. Ferruzzi, M. G.; Lobo, J. K.; Janle, E. M.; Cooper, B.; Simon, J. E.; Wu, Q. L.; Welch, C.; Ho, L.; Weaver, C.; Pasinetti, G. M. Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer's disease. J. Alzheimer Dis. 2009, 18, 113-124.
14. Gasperotti, M.; Passamonti, S.; Tramer, F.; Masuero, D.; Guella, G.; Mattivi, F.; Vrhovsek, U. Fate of microbial metabolites of dietary polyphenols in rats: is the brain their target destination? ACS Chem. Neurosci. 2015, 6, 1341-1352.
15. Yan, L.; Yin, P.; Ma, C.; Liu, Y. Method development and validation for pharmacokinetic and tissue distributions of ellagic acid using ultrahigh performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). Molecules 2014, 19, 18923-18935.
16. Azorín-Ortuno, M.; Yanez-Gascon, M. J.; Vallejo, F.; Pallares, F. J.; Larrosa, M.; Lucas, R.; Morales, J. C.; Tomas-Barberan, F. A.; García-Conesa, M. T.; Espín, J. C. Metabolites and tissue distribution of resveratrol in the pig. Mol. Nutr. Food Res. 2011, 55, 1154-1168.
17. Andres-Lacueva, C.; Shukitt-Hale, B.; Galli, R. L.; Jauregui, O.; Lamuela-Raventos, R. M.; Joseph, J. A. Anthocyanins in aged blueberry-fed rats are found centrally and may enhance memory. Nutr. Neurosci. 2005, 8, 111-120.
18. Fornasaro, S.; Ziberna, L.; Gasperotti, M.; Tramer, F.; Vrhovsek, U.; Mattivi, F.; Passamonti, S. Determination of cyanidin-3-glucoside in rat brain, liver and kidneys by UPLC/MS-MS and its application to a short-term phamacokinetic study. Sci. Rep. 2016, 6, 22815.
19. Del Rio, D.; Rodriguez-Mateos, A.; Spencer, J. P.; Tognolini, M.; Borges, G.; Crozier, A. Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxid. Redox Signaling 2013, 18, 1818-1892.
20. Hu, N.; Yu, J. T.; Tan, L.; Wang, Y. L.; Sun, L.; Tan, L. Nutrition and the risk of Alzheimer's diseases. BioMed Res. Int. 2013, 2013, 524820.
21. Gonzalez-Sarrías, A.; Nunez-Sanchez, M. A.; García-Villalba, R.; Tomas-Barberan, F. A.; Espín, J. C. Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: the role of cell metabolism. Eur. J. Nutr. 2015, DOI: 10.1007/s00394-015-1131-7.
22. Darvesh, A. S.; Carroll, R. T.; Bishayee, A.; Geldenhuys, W. J.; Van der Schyf, C. J. Oxidative stress and Alzheimer's disease: dietary polyphenols as potential therapeutic agents. Expert Rev. Neurother. 2010, 10, 729-745.
23. Spencer, J. P. E.; Vafeiadou, K.; Williams, R. J.; Vauzour, D. Neuroinflammation: modulation by flavonoids and mechanisms of action. Mol. Aspects Med. 2012, 33, 83-97.
24. Pandareesh, M. D.; Mythri, R. B.; Srinivas Bharath, M. M. Bioavailability of dietary polyphenols: Factors contributing to their clinical application in CNS diseases. Neurochem. Int. 2015, 89, 198-208.
25. Mattson, M. P. Neuronal life-and-death signaling, apoptosis, and neurodegenerative disorders. Antioxid. Redox Signaling 2006, 8, 1997-2006.
26. Valencia, A.; Moran, J. Reactive oxygen species induce different cell death mechanisms in cultured neurons. Free Radical Biol. Med. 2004, 36, 1112-1125.
27. Wang, X.; Wang, W.; Li, L.; Perry, G.; Lee, H. G.; Zhu, X. Oxidative stress and mitochondrial dysfunction in Alzheimer's disease. Biochim. Biophys. Acta, Mol. Basis Dis. 2014, 1842, 1240-1247.
28. Park, H. R.; Lee, H.; Park, H.; Jeon, J. W.; Cho, W. K.; Ma, J. Y. Neuroprotective effects of Liriope platyphylla extract against hydrogen peroxide-induced cytotoxicity in human neuroblastoma SH-SY5Y cells. BMC Complementary Altern. Med. 2015, 15, 171.
29. Law, B. N.; Ling, A. P.; Koh, R. Y.; Chye, S. M.; Wong, Y. P. Neuroprotective effects of orientin on hydrogen peroxide induced apoptosis in SH SY5Y cells. Mol. Med. Rep. 2014, 9, 947-954.
30. Garcimartín, A.; Merino, J. J.; Gonzalez, M. P.; Sanchez-Reus, M. I.; Sanchez-Muniz, F. J.; Bastida, S.; Benedí, J. Organic silicon protects human neuroblastoma SH-SY5Y cells against hydrogen peroxide effects. BMC Complementary Altern. Med. 2014, 14, 384.
31. Braidy, N.; Jugder, B. E.; Poljak, A.; Jayasena, T.; Mansour, H.; Nabavi, S. M.; Sachdev, P.; Grant, R. Resveratrol as a potential therapeutic candidate for the treatment and management of Alzheimer's disease. Curr. Top. Med. Chem. 2016, 16, 1951-1960.
32. Tome-Carneiro, J.; Larrosa, M.; Gonzalez-Sarrías, A.; Tomas-Barberan, F. A.; García-Conesa, M. T.; Espín, J. C. Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence. Curr. Pharm. Des. 2013, 19, 6064-6093.
33. de Almeida, L. M.; Leite, M. C.; Thomazi, A. P.; Battu, C.; Nardin, P.; Tortorelli, L. S.; Zanotto, C.; Posser, T.; Wofchuk, S. T.; Leal, R. B.; Goncalves, C. A.; Gottfried, C. Resveratrol protects against oxidative injury induced by H2O2 in acute hippocampal slice preparations from Wistar rats. Arch. Biochem. Biophys. 2008, 480, 27-32.
34. Quincozes-Santos, A.; Andreazza, A. C.; Nardin, P.; Funchal, C.; Goncalves, C. A.; Gottfried, C. Resveratrol attenuates oxidative-induced DNA damage in C6 Glioma cells. NeuroToxicology 2007, 28, 886-891.
35. Turner, R. S.; Thomas, R. G.; Craft, S.; van Dyck, C. H.; Mintzer, J.; Reynolds, B. A.; Brewer, J. B.; Rissman, R. A.; Raman, R.; Aisen, P. S. A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease. Neurology 2015, 85, 1383-1391.
36. Daglia, M.; Di Lorenzo, A.; Nabavi, S. F.; Talas, Z. S.; Nabavi, S. M. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat! Curr. Pharm. Biotechnol. 2014, 15, 362-372.
37. de Oliveira, M. R. The effects of ellagic acid upon brain cells: a mechanistic view and future directions. Neurochem. Res. 2016, 41, 1219-1228.
38. Gonzalez-Sarrías, A.; García-Villalba, R.; Nunez-Sanchez, M. A.; Tome-Carneiro, J.; Zafrilla, P.; Mulero, J.; Tomas-Barberan, F. A.; Espín, J. C. Identifying the limits for ellagic acid bioavailability: a crossover pharmacokinetic study in healthy volunteers after consumption of pomegranate extracts. J. Funct. Foods 2015, 19, 225-235.
39. Sanchez-Gonzalez, C.; Ciudad, C.; Noe, V.; Izquierdo-Pulido, M. Health benefits of walnut polyphenols: an exploration beyond their lipid profile. Crit. Rev. Food Sci. Nutr. 2015, DOI: 10.1080/10408398.2015.1126218.
40. Kim, M. J.; Seong, A. R.; Yoo, J. Y.; Jin, C. H.; Lee, Y. H.; Kim, Y. J.; Lee, J.; Jun, W. J.; Yoon, H. G. Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol. Nutr. Food Res. 2011, 55, 1789-1808.
41. Martín, S.; Gonzalez-Burgos, E.; Carretero, M. E.; Gomez-Serranillos, M. P. Neuroprotective properties of Spanish red wine and its isolated polyphenols on astrocytes. Food Chem. 2011, 128, 40-48.
42. Tomas-Barberan, F. A.; Gonzalez-Sarrías, A.; García-Villalba, R.; Nunez-Sanchez, M. A.; Selma, M. V.; García-Conesa, M. T.; Espín, J. C. Urolithins, the rescue of 'old' metabolites to understand a 'new' concept: metabotypes as a nexus between phenolic metabolism, microbiota dysbiosis and host health status. Mol. Nutr. Food Res. 2016, DOI: 10.1002/mnfr.201500901.
43. Verzelloni, E.; Pellacani, C.; Tagliazucchi, D.; Tagliaferri, S.; Calani, L.; Costa, L. G.; Brighenti, F.; Borges, G.; Crozier, A.; Conte, A.; Del Rio, D. Antiglycative and neuroprotective activity of colon-derived polyphenol catabolites. Mol. Nutr. Food Res. 2011, 55, 35-43.
44. Yuan, T.; Ma, H.; Liu, W.; Niesen, D. B.; Shah, N.; Crews, R.; Rose, K. N.; Vattem, D. A.; Seeram, N. P. Pomegranate's neuroportective effects against Alzheimer's disease are mediated by urolithins, its ellagitannin-gut microbial metabolites. ACS Chem. Neurosci. 2016, 7, 26-33.
45. Urpi-Sarda, M.; Monagas, M.; Khan, N.; Llorach, R.; Lamuela-Raventos, R. M.; Jauregui, O.; Estruch, R.; Izquierdo-Pulido, M.; Andres-Lacueva, C. Targeted metabolic profiling of phenolics in urine and plasma after regular consumption of cocoa by liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2009, 1216, 7258-7267.
46. Monagas, M.; Urpi-Sarda, M.; Sanchez-Patan, F.; Llorach, R.; Garrido, I.; Gomez-Cordoves, C.; Andres-Lacueva, C.; Bartolome, B. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food Funct. 2010, 1, 233-253.
47. Beking, K.; Vieira, A. Flavonoid intake and disability-adjusted life years due to Alzheimer's and related dementias: a population-based study involving twenty-three developed countries. Public Health Nutr. 2010, 13, 1403-1409.
48. Sokolov, A. N.; Pavlova, M. A.; Klosterhalfen, S.; Enck, P. Chocolate and the brain: neurobiological impact of cocoa flavanols on cognition and behavior. Neurosci. Biobehav. Rev. 2013, 37, 2445-2453.